Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Medicine and Science in Sports|January 1, 1978
Physiological alterations consequent to circuit weight trainingJ H Wilmore, R B Parr, R N Girandola, et al.
International Journal of Immunogenetics|February 8, 2007
Genetic diversity of the IL-4, IL-4 receptor and IL-13 loci in mestizos in the general population and in patients with asthma from three subpopulations in MexicoK I M López, S E F Martínez, M C M Moguel, et al.
Ophthalmic Genetics|March 12, 2019
Clinical features and possible founder mutation of the 8bp duplication mutation in the SLC4A11 gene causing corneal dystrophy and perceptive deafness in three South American familiesPablo T Romero, Rodrigo Donoso, Pamela López, et al.
Leukemia|March 18, 2015
The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fateV Ayllón, C Bueno, V Ramos-Mejía, et al.
Injury|June 16, 2015
"A short trauma course for physicians in a resource-limited setting: Is low-cost simulation effective?"K Pringle, J M Mackey, P Modi, et al.
The Laryngoscope|May 29, 2026
Synchrotron-Based Deep Learning Network of the Inner Ear: Development and Expert ValidationAshley Micuda, Kyle Rioux, Luke Helpard, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|October 1, 1991
[Ectopic gastric mucosa in the proximal esophagus]R Santana Ramírez, L Peña Quintana, T Romero Saavedra, et al.
Plant Cell Reports|August 2, 2015
A high efficient protocol for soybean root transformation by Agrobacterium rhizogenes and most stable reference genes for RT-qPCR analysisK M Kuma, V S Lopes-Caitar, C C T Romero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2022
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket studyV Subbiah, R J Kreitman, Z A Wainberg, et al.
Leukemia Research|April 19, 2025
Safety and efficacy of the combination of azacitidine with venetoclax after hypomethylating agent failure in higher-risk myelodysplastic syndromeJulie S Braish, Guillermo Montalban-Bravo, Farhad Ravandi, et al.
Pageof 12